HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

NK 252

potentiates the action of antitumor drugs against drug-sensitive tumors; structure given in first source
Also Known As:
NK-252
Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Aoki, Takumi: 1 article (07/2013)
2. Mochizuki, Hidenori: 1 article (07/2013)
3. Asaoka, Yoshiji: 1 article (07/2013)
4. Kaino, Mie: 1 article (07/2013)
5. Yoshizawa, Yoshitaka: 1 article (07/2013)
6. Yamada, Masateru: 1 article (07/2013)
7. Noda, Hidetoshi: 1 article (07/2013)
8. Shimozono, Rieko: 1 article (07/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Leukemia
3. Fibrosis (Cirrhosis)

Related Drugs and Biologics

1. Vindesine (Vindesin)
2. Vincristine (Oncovin)
3. Vinblastine (Vinblastine Sulfate)
4. Dactinomycin (Ac-De)
5. Antineoplastic Agents (Antineoplastics)
6. NK 250
7. 1,4-dihydropyridine (dihydropyridine)
8. CDAA (Randox)